ICU Medical
Open
$142.26
Prev. Close
$142.41
High
$142.42
Low
$141.86
Market Snapshot
$3.51B
75.8
-4.84
$2.38B
ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 13,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume intravenous (IV) pumps and safety software, dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions. Its product offerings also include Consumables, Infusion Systems and Vital Care. Its consumables business unit includes infusion therapy, oncology, vascular access, and tracheostomy products. Its infusion systems offer a portfolio of infusion pumps, software, and professional services. Its vital care business unit includes hemodynamic monitoring, general anesthesia and respiratory, temperature management solutions and regional anesthesia/pain management products. Its infusion therapy products include infusion sets, extension sets, needle-free connectors, and disinfection caps.
ICU Medical's VP divested 2,447 shares as Madison Small Cap Fund made a new investment, reflecting varied confidence in the company's market prospects.
ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 13,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume intravenous (IV) pumps and safety software, dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions. Its product offerings also include Consumables, Infusion Systems and Vital Care. Its consumables business unit includes infusion therapy, oncology, vascular access, and tracheostomy products. Its infusion systems offer a portfolio of infusion pumps, software, and professional services. Its vital care business unit includes hemodynamic monitoring, general anesthesia and respiratory, temperature management solutions and regional anesthesia/pain management products. Its infusion therapy products include infusion sets, extension sets, needle-free connectors, and disinfection caps.
Recently from Cashu
ICU Medical (ICUI) Schedules Q4 Earnings Release Feb. 19, 2026 at 4:05 p.m. ET
ICU Medical timestamps quarter-end disclosure ICU Medical (NASDAQ: ICUI) releases its fourth-quarter earnings statement on Thursday, Feb. 19, 2026 at 4:05 p.m. ET, completing its formal reporting for…
ICU Medical earnings release is operational checkpoint for infusion franchise, margins and R&D
Earnings release frames operational checkpoint for infusion specialist ICU Medical is set to publish its quarterly results on Thursday, 2026-02-19, delivering a concise operational update that stakeho…
ICU Medical Quarterly Results Preview: Product Adoption, Margin Initiatives and Guidance on Feb. 19
ICU Medical prepares to report operating results in a closely watched quarterly filing that market participants treat as an update on recent commercial and margin trends rather than a pure financial e…
ICU Medical Earnings Preview: Infusion Therapy Adoption, Margin Trajectory, Supply-Chain and R&D
Earnings Briefing Ahead of Thursday Release ICU Medical is set to release its quarterly results on Thursday, 2026-02-19, and expects the filing to serve as a compact operational update for the medical…